Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine Griffett

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Molecular Metabolism|April 2, 2015
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisKristine Griffett, Ryan D Welch, Colin A Flaveny, et al.
Bioorganic Chemistry|December 13, 2021
Synthesis and structure activity relationship of the first class of LXR inverse agonistsBahaa Elgendy, Kristine Griffett, Lamees Hegazy, et al.
Plos One|March 26, 2021
A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosisMonideepa Sengupta, Suomia Abuirqeba, Amina Kameric, et al.
Metabolites|March 24, 2022
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASHRyan D Welch, Cyrielle Billon, McKenna Losby, et al.
Pharmacological Reviews|March 5, 2013
Nuclear receptors and their selective pharmacologic modulatorsThomas P Burris, Laura A Solt, Yongjun Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Cell Chemical Biology|August 9, 2020
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural RetinoidsKristine Griffett, Gonzalo Bedia-Diaz, Lamees Hegazy, et al.
ACS Chemical Biology|April 13, 2022
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse AgonistsKristine Griffett, Matthew Hayes, Gonzalo Bedia-Diaz, et al.
Nature Communications|December 24, 2014
Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviourSubhashis Banerjee, Yongjun Wang, Laura A Solt, et al.
Cancer Cell|June 30, 2015
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisColin A Flaveny, Kristine Griffett, Bahaa El-Dien M El-Gendy, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecular Metabolism|April 2, 2015
The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitisKristine Griffett, Ryan D Welch, Colin A Flaveny, et al.
Bioorganic Chemistry|December 13, 2021
Synthesis and structure activity relationship of the first class of LXR inverse agonistsBahaa Elgendy, Kristine Griffett, Lamees Hegazy, et al.
Plos One|March 26, 2021
A two-hit model of alcoholic liver disease that exhibits rapid, severe fibrosisMonideepa Sengupta, Suomia Abuirqeba, Amina Kameric, et al.
Metabolites|March 24, 2022
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASHRyan D Welch, Cyrielle Billon, McKenna Losby, et al.
Pharmacological Reviews|March 5, 2013
Nuclear receptors and their selective pharmacologic modulatorsThomas P Burris, Laura A Solt, Yongjun Wang, et al.
Bioorganic & Medicinal Chemistry Letters|December 28, 2018
Development of novel liver X receptor modulators based on a 1,2,4-triazole scaffoldShaimaa S Goher, Kristine Griffett, Lamees Hegazy, et al.
Cell Chemical Biology|August 9, 2020
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural RetinoidsKristine Griffett, Gonzalo Bedia-Diaz, Lamees Hegazy, et al.
ACS Chemical Biology|April 13, 2022
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse AgonistsKristine Griffett, Matthew Hayes, Gonzalo Bedia-Diaz, et al.
Nature Communications|December 24, 2014
Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviourSubhashis Banerjee, Yongjun Wang, Laura A Solt, et al.
Cancer Cell|June 30, 2015
Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and LipogenesisColin A Flaveny, Kristine Griffett, Bahaa El-Dien M El-Gendy, et al.
Pageof 3